Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenyan Sun

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Arthritis Research & Therapy|March 10, 2022
A machine learning-assisted model for renal urate underexcretion with genetic and clinical variables among Chinese men with goutMingshu Sun, Wenyan Sun, Xuetong Zhao, et al.
Rheumatology (Oxford, England)|September 16, 2022
Profiling of serum oxylipins identifies distinct spectrums and potential biomarkers in young people with very early onset goutCan Wang, Jie Lu, Wenyan Sun, et al.
Seminars in Arthritis and Rheumatism|February 9, 2024
Clinical characteristics of adolescent-onset gout in Chinese: A hospital-based cross-sectional studyYushuang Li, Tony R Merriman, Haibing Chen, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 18, 2024
A stable liver-specific urate oxidase gene knockout hyperuricemia mouse model finds activated hepatic de novo purine biosynthesis and urate nephropathyLei Pang, Ningning Liang, Changgui Li, et al.
Arthritis Research & Therapy|September 4, 2019
Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohortNan Liang, Mingshu Sun, Ruixia Sun, et al.
Arthritis Research & Therapy|February 19, 2026
Effects of adding urinary alkalizer citrate mixture to febuxostat in gout patients with combined-type hyperuricemia and low urine pH: a prospective cohort studyKai Guo, Changgui Li, Robert Terkeltaub, et al.
Rheumatology (Oxford, England)|November 6, 2024
An artificial intelligence-based gout management system reduced chronic kidney disease incident and improved target serum urate achievementHan Qi, Jie Lu, Nicola Dalbeth, et al.
Seminars in Arthritis and Rheumatism|February 29, 2024
The value of musculoskeletal ultrasound in predicting gout flares in index joints: A prospective cohort study of people with gout starting urate-lowering therapyLin Han, Runze Li, Nicola Dalbeth, et al.
Rheumatology (Oxford, England)|February 11, 2025
Impact of adding urine alkalization therapy to xanthine oxidase inhibitor in gout management: a prospective cohort studyCan Wang, Kai Guo, Nicola Dalbeth, et al.
Rheumatology (Oxford, England)|November 19, 2020
The efficacy and safety of citrate mixture vs sodium bicarbonate on urine alkalization in Chinese primary gout patients with benzbromarone: a prospective, randomized controlled studyXiaomei Xue, Zhen Liu, Xinde Li, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Arthritis Research & Therapy|March 10, 2022
A machine learning-assisted model for renal urate underexcretion with genetic and clinical variables among Chinese men with goutMingshu Sun, Wenyan Sun, Xuetong Zhao, et al.
Rheumatology (Oxford, England)|September 16, 2022
Profiling of serum oxylipins identifies distinct spectrums and potential biomarkers in young people with very early onset goutCan Wang, Jie Lu, Wenyan Sun, et al.
Seminars in Arthritis and Rheumatism|February 9, 2024
Clinical characteristics of adolescent-onset gout in Chinese: A hospital-based cross-sectional studyYushuang Li, Tony R Merriman, Haibing Chen, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 18, 2024
A stable liver-specific urate oxidase gene knockout hyperuricemia mouse model finds activated hepatic de novo purine biosynthesis and urate nephropathyLei Pang, Ningning Liang, Changgui Li, et al.
Arthritis Research & Therapy|September 4, 2019
Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohortNan Liang, Mingshu Sun, Ruixia Sun, et al.
Arthritis Research & Therapy|February 19, 2026
Effects of adding urinary alkalizer citrate mixture to febuxostat in gout patients with combined-type hyperuricemia and low urine pH: a prospective cohort studyKai Guo, Changgui Li, Robert Terkeltaub, et al.
Rheumatology (Oxford, England)|November 6, 2024
An artificial intelligence-based gout management system reduced chronic kidney disease incident and improved target serum urate achievementHan Qi, Jie Lu, Nicola Dalbeth, et al.
Seminars in Arthritis and Rheumatism|February 29, 2024
The value of musculoskeletal ultrasound in predicting gout flares in index joints: A prospective cohort study of people with gout starting urate-lowering therapyLin Han, Runze Li, Nicola Dalbeth, et al.
Rheumatology (Oxford, England)|February 11, 2025
Impact of adding urine alkalization therapy to xanthine oxidase inhibitor in gout management: a prospective cohort studyCan Wang, Kai Guo, Nicola Dalbeth, et al.
Rheumatology (Oxford, England)|November 19, 2020
The efficacy and safety of citrate mixture vs sodium bicarbonate on urine alkalization in Chinese primary gout patients with benzbromarone: a prospective, randomized controlled studyXiaomei Xue, Zhen Liu, Xinde Li, et al.
Pageof 13